Oral octreotide efficacy maintained in more than 90% of adults with acromegaly at 3 years
June 20, 2022
Endocrine Today reports on the results of a clinical trial of a new oral medication to treat acromegaly, a pituitary disorder. Maria Fleseriu, M.D., reported promising results at a national conference.